GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Net Issuance of Debt

Biomics Biopharma (ASX:BBM) Net Issuance of Debt : A$0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Biomics Biopharma's net issuance of debt for the six months ended in . 20 was A$0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

Biomics Biopharma Net Issuance of Debt Historical Data

The historical data trend for Biomics Biopharma's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Net Issuance of Debt Chart

Biomics Biopharma Annual Data
Trend
Net Issuance of Debt

Biomics Biopharma Semi-Annual Data
Net Issuance of Debt

Biomics Biopharma Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Debt for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Net Issuance of Debt
Comparable Companies
ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA
Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Website
http://www.biomics.com
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines